Register today for a LIVE national broadcast on New Treatment Options for Rare Diseases in the Soft Tissue for March 5th and 6th!

News >

Neoadjuvant Chemo Shows Comparable Data to Upfront Surgery in Ovarian Cancer

Ellie Leick
Published: Thursday, Aug 08, 2019

Michelle M. Boisen, MD

Michelle M. Boisen, MD

Recent trials, such as the SCORPION study, continue to compare the outcomes of patients who undergo upfront surgery versus neoadjuvant chemotherapy in ovarian cancer, and could address unanswered questions in the community, explained Michelle M. Boisen, MD.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication